Provider Resources WA

08/01/24 Provider Alert: Ongoing transmission of Candida auris identified in Washington.

Background C. auris is an emerging, often multi-drug resistant yeast, that was first identified in the US in 2009. The first locally acquired case of C. auris in Washington was reported in 2023, and the first outbreak was  reported in January 2024. It can cause difficult to control outbreaks in high acuity facilities, especially among 08/01/24 Provider Alert: Ongoing transmission of Candida auris identified in Washington.

05/07/24 Health Advisory: Invasive Serogroup Y Meningococcal Disease Increasing in the United States

Black triangle with ! "Health Advisory" on yellow background

Summary Increase nationwide On March 28, 2024, CDC (Centers for Disease Control and Prevention) issued a health advisory about the increase in invasive serogroup Y meningococcal disease in the United States. Washington has not seen an increase in cases. Washington had 4 confirmed cases of meningococcal disease in 2023. Providers have reported 3 confirmed cases so far 05/07/24 Health Advisory: Invasive Serogroup Y Meningococcal Disease Increasing in the United States

03/27/2024 Health Advisory: Measles Increasing in Washington, the Nation, and the World

Summary Background Measles is a highly contagious viral illness that can lead to severe health complications, like pneumonia, encephalitis, and death, especially in unvaccinated people. Measles outbreaks have occurred in Washington, the United States, and around the world in 2024. Outbreaks often start when an unvaccinated or under-vaccinated person is exposed during international travel and 03/27/2024 Health Advisory: Measles Increasing in Washington, the Nation, and the World

01/19/24 Health Advisory: Measles Outbreak in Southwest Washington

Person with head down, covering mouth with hand

An active measles outbreak investigation is underway in Clark and Wahkiakum Counties. As of Jan. 10, 2024, investigators have identified 3 lab-confirmed and 3 epidemiologically linked measles cases in unvaccinated adults. Symptoms began in mid-to-late December. All report isolating at home during their contagious period. Investigators have not identified any public exposure locations. Healthcare providers 01/19/24 Health Advisory: Measles Outbreak in Southwest Washington

12/15/23 Health Advisory: Test for tuberculosis people who were incarcerated

TB Skin Test

A large outbreak of tuberculosis (TB) in the state prison system may affect more than 800 people who were incarcerated. Requested actions Ask patients about risk factors for TB exposure: Test people with risk factors unless they have a known history of TB infection or TB disease. Evaluate people who test positive to rule out 12/15/23 Health Advisory: Test for tuberculosis people who were incarcerated

09/20/23 Health Advisory: New COVID-19 Vaccines Authorized, Previous Bivalent COVID-19 Vaccines Deauthorized

hands in blue medical gloves holding a syringe and drawing from a vile

FDA deauthorized previous bivalent COVID-19 vaccines. On Sept. 11, 2023, FDA deauthorized previous bivalent COVID-19 vaccines from Moderna and Pfizer. CDC recommends new, updated (2023–2024) COVID-19 vaccines. CDC’s new, updated (2023–2014) COVID-19 vaccine recommendations: Vaccination remains the best way to prevent COVID-19 hospitalization and death and reduces the risk of long COVID. The new, updated 09/20/23 Health Advisory: New COVID-19 Vaccines Authorized, Previous Bivalent COVID-19 Vaccines Deauthorized

04/24/23 Health Advisory: Bivalent COVID-19 Vaccine Use Expanded, Monovalent No Longer Authorized

Warning yellow triangle with black exclamation point on left. "Health Advisory" on right.

Requested actions Monovalent Moderna and Pfizer COVID-19 vaccines are no longer authorized for use in the United States. Read below for how to discard and report as waste. Use the new simplified schedule to administer COVID-19 vaccine. People who are 65 years or older or have immune compromise can now get a second bivalent booster 04/24/23 Health Advisory: Bivalent COVID-19 Vaccine Use Expanded, Monovalent No Longer Authorized

04/20/23 Health Advisory: Tuberculosis Testing and Treatment for People Newly Arrived from Ukraine

Person sitting at a desk, with clipboard and pend, holding a chest X-ray,

Requested actions Test for tuberculosis (TB) people newly arrived from Ukraine, within 90 days of arriving in the United States. Test result Action Positive IGRA or TST Order chest X-ray. Positive IGRA or TST and normal chest x-ray Offer and encourage latent TB infection (LTBI) treatment. Positive IGRA or TST and abnormal chest x-ray Contact 04/20/23 Health Advisory: Tuberculosis Testing and Treatment for People Newly Arrived from Ukraine

03/14/23 Health Advisory: Extensively Drug-Resistant Shigellosis

Pair of hands lathering soap over a steel sink

Requested actions Background Shigellosis is an acute enteric infection. It is an important cause of domestically acquired and travel-associated bacterial diarrhea in the United States. A low infectious dose makes Shigella bacteria easily transmitted from person to person. Consider shigellosis in the differential diagnosis of acute diarrhea, especially in people who: Shigellosis can be a mild, 03/14/23 Health Advisory: Extensively Drug-Resistant Shigellosis

02/22/23 Health Advisory: Increase COVID-19 Treatment Access, Prescribing and Uptake

close up of a line of prescription pill bottles

COVID-19 treatment is shown to reduce hospitalization. Yet it is under-used for high-risk patients with acute COVID-19. High-risk patients are: COVID-19 continues to cause 2,000 to 3,000 deaths each week in the United States. On Feb. 6, Washington State Department of Health (DOH) relaunched its free telehealth program. The program, in partnership with Color Health, 02/22/23 Health Advisory: Increase COVID-19 Treatment Access, Prescribing and Uptake